T1	Participants 30 61	chronic immune thrombocytopenia
T2	Participants 292 337	patients with chronic immune thrombocytopenia
T3	Participants 437 583	adults with previously treated immune thrombocytopenia of more than 6 months' duration who had baseline platelet counts lower than 30,000 per Î¼L.
T4	Participants 952 958	status
T5	Participants 1463 1525	FINDINGS Between Nov 22, 2006, and July 31, 2007, 197 patients
T6	Participants 2856 2929	beneficial for patients who have not responded to splenectomy or previous
